Skip to main content

ITRS, Excelian Partner on Murex Systems Monitoring

kevin-covington-itrs-033-resized
Kevin Covington, ITRS

The project will run on ITRS's Geneos monitoring platform and take advantage of Excelian's established position as a top-tier alliance partner with Murex. The pair will continue to work together as part of ITRS's developer program, as well.

“The Murex trading platform is highly developed and a market-leader with numerous global financial clients worldwide. Our developer program is continuously expanding to bring tangible benefits to our clients in providing them with end-to-end monitoring across different segments of financial markets, different parts of the trade lifecycle, technologies and geographies," Kevin Covington, CEO of ITRS, says.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

‘Vibe coding is burning us out’

Vibe coding is rapidly spreading throughout the capital markets, and some are unhappy about it, while others believe the genie is out of the bottle. Engineers spoken to for this story share some choice words—and several expletives—about this new form of coding.

DTCC dives into public cloud

The clearing house has begun migrating its equities clearing and settlement systems to AWS, while its tokenization systems have migrated to Microsoft Azure ahead of their launch this fall.

Solving the last line of latency

Repurposed copper cables and hollow-core fiber can optimize latency even for firms who feel they’ve hit a ceiling, writes Vahan Sardaryan in this guest column.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here